Integra Lifesciences 

$18.08
5
+$0.31+1.74% Today

Statistics

Day High
18.19
Day Low
17.67
52W High
18.08
52W Low
8.9
Volume
12,397,201
Avg. Volume
-
Mkt Cap
1.41B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29JulExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
0.39
0.58
0.78
0.97
Expected EPS
0.4836
Actual EPS
N/A

Financials

-31.58%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
3.27BRevenue
-1.03BNet Income

Analyst Ratings

14.33Average Price Target
The highest estimate is 16.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IART. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Stryker
SYK
Mkt Cap119.69B
Stryker Corporation competes directly with Integra Lifesciences in the medical technology and surgical instruments sector, offering similar products for neurosurgery and orthopedics.
Medtronic
MDT
Mkt Cap102.97B
Medtronic plc offers a wide range of medical devices that compete with Integra's offerings, especially in the neurosurgery and spinal products market.
Johnson & Johnson
JNJ
Mkt Cap579.83B
Johnson & Johnson, through its medical devices segment, competes in various areas including surgical products and wound care, overlapping with Integra's product lines.
Zimmer Biomet
ZBH
Mkt Cap17.13B
Zimmer Biomet Holdings, Inc. competes in the orthopedic and neurosurgery sectors, offering products that directly compete with Integra's surgical instruments and implants.
Boston Scientific
BSX
Mkt Cap69.72B
Boston Scientific Corporation offers products in the neuromodulation and neurovascular sectors, competing with Integra Lifesciences' neurosurgical product lines.
Globus Medical
GMED
Mkt Cap10.91B
Globus Medical, Inc. focuses on musculoskeletal solutions, including innovative spinal and orthopedic surgery products, competing with Integra's offerings.
Integra Lifesciences
IART
Mkt Cap1.32B
Integra Lifesciences competes with itself through its diverse range of products, constantly innovating and expanding its portfolio to stay competitive in the market.
Alphatec
ATEC
Mkt Cap1.22B
Alphatec Holdings, Inc. is a provider of spinal surgery solutions, competing in the same space as Integra Lifesciences with its focus on innovative spinal products and technologies.

About

Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.
Show more...
CEO
Dr. Stuart M. Essig Ph.D.
Employees
4396
Country
United States
ISIN
US4579852082

Listings

0 Comments

Share your thoughts

FAQ

What is Integra Lifesciences stock price today?
The current price of IART is $18.08 USD — it has increased by +1.74% in the past 24 hours. Watch Integra Lifesciences stock price performance more closely on the chart.
What is Integra Lifesciences stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Integra Lifesciences stocks are traded under the ticker IART.
Is Integra Lifesciences stock price growing?
IART stock has risen by +6.43% compared to the previous week, the month change is a +27.87% rise, over the last year Integra Lifesciences has showed a +48.27% increase.
What is Integra Lifesciences market cap?
Today Integra Lifesciences has the market capitalization of 1.41B
When is the next Integra Lifesciences earnings date?
Integra Lifesciences is going to release the next earnings report on July 29, 2026.
What were Integra Lifesciences earnings last quarter?
IART earnings for the last quarter are 0.54 USD per share, whereas the estimation was 0.4 USD resulting in a +33.35% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Integra Lifesciences revenue for the last year?
Integra Lifesciences revenue for the last year amounts to 3.27B USD.
What is Integra Lifesciences net income for the last year?
IART net income for the last year is -1.03B USD.
How many employees does Integra Lifesciences have?
As of June 15, 2026, the company has 4,396 employees.
In which sector is Integra Lifesciences located?
Integra Lifesciences operates in the Health & Wellness sector.
When did Integra Lifesciences complete a stock split?
The last stock split for Integra Lifesciences was on January 04, 2017 with a ratio of 2:1.
Where is Integra Lifesciences headquartered?
Integra Lifesciences is headquartered in Princeton, United States.